MicroRNA 5583-1 (MIR5583-1)

MicroRNA 5583-1 (MIR5583-1) is annotated as a human microRNA gene, part of a family of small non-coding RNAs (microRNAs) that function primarily as post-transcriptional regulators of gene expression and RNA interference molecules[3][4]. MicroRNAs typically modulate gene expression by binding complementary sequences in the 3' untranslated regions (3' UTRs) of target mRNAs, thereby leading to translational repression or mRNA degradation. The majority of these interactions are driven by the seed region of the microRNA (nucleotides 2-7/8), with imperfect pairing in animals, often causing inhibition of protein translation or mRNA decay[3][4]. MicroRNAs are classified as non-coding RNAs rather than canonical therapeutic targets such as receptors, enzymes, or ion channels[3][4]. No published literature or pathway database entry currently elucidates the physiological, disease, or therapeutic relevance specifically for MIR5583-1, nor are there known drugs, biomarkers, or safety concerns associated with it. Is_target: False. MicroRNAs like MIR5583-1 are regulators and rarely direct therapeutic targets (such as receptor, enzyme, transporter, etc.), although they can in principle be targeted by nucleic acid-based therapies[2][3][4]. Is_incorrect: True. Direct, target-specific mechanistic, functional, or disease-relevance data on MIR5583-1 are missing, indicating this entry is either too obscure or not established as a bona fide target. General context: MicroRNAs play essential roles in development, physiology, and disease pathobiology, governing regulatory networks at a system level and acting as non-coding RNA regulators, but only a minority are established as direct disease biomarkers or therapeutic targets[2][3][4][5]. MIR5583-1 itself is not prominent in the literature, and its specific function, disease role, or therapeutic relevance is uncharacterized in existing comprehensive sources.

Other names

hsa-mir-5583-1MIR5583-1microRNA 5583-1